trending Market Intelligence /marketintelligence/en/news-insights/trending/wdfcpdxxgszgufhq6ymkdq2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Halyard Health board approves next phase of restructuring

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Halyard Health board approves next phase of restructuring

Halyard Health Inc. approved the next phase of its previously announced restructuring plan.

The Alpharetta, Ga.-based medical technology company approved the initial phase of a multiyear restructuring plan in December 2017 to coincide with the divestiture of its surgical and infection prevention business to Owens & Minor, Inc. for about $710 million in cash.

The transaction includes the sale of Halyard's information technology systems, prompting the company to migrate to a platform the company said is more appropriate for its business and size.

The migration, approved by the company's board, is expected to cost between $40 million and $50 million. The company estimates that it will save between $15 million and $19 million in annual costs as a result of the restructuring, which it estimates will be completed by the end of 2019.

Halyard expects to decrease information technology-related costs by about $13 million to $17 million per year with the sale of the surgical business and the reduced scale of its operations.

The company projects that annually, total direct costs to support the enhanced IT systems will be about half of the costs incurred during 2017 to support its existing IT system.

Halyard will disclose additional phases of the plan, including potential supply chain and go-to-market restructurings, when they are approved.